{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:59:52Z","timestamp":1790740792510,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Optimal perioperative antibiotic prophylaxis in kidney transplantation remains undefined despite routine antibiotic administration to prevent infections. In this retrospective observational cohort study with historical comparison, we compared the clinical efficacy of 6 days of ampicillin\/sulbactam vs. a single dose of cefazolin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 2322 kidney transplantation recipients at a single center, with the evaluation period spanning from 2015 through 2021. Patients were divided into 2 groups based on the perioperative antibiotic regimen received: 971 patients received ampicillin\/sulbactam, and 1351 received cefazolin. This study focused on evaluating the impact of these regimens on postoperative infection incidence and the 6-month acute rejection (AR) rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cefazolin group exhibited a tendency toward higher urinary tract infection rates within 1 month after transplantation (3.4% vs. 2.2%, p=\u2009=\u20090.078). There were no significant differences in surgical site infections between the groups. The 6-month AR rates were significantly lower in the cefazolin group than in the ampicillin\/sulbactam group (5.1% vs. 7.9%, p=\u2009=\u20090.009). Cefazolin was also confirmed to be significantly associated with reduced 6-month AR rates in the multivariable logistic regression analysis (odds ratio 0.63, 95% confidence interval [0.45-0.89], p=\u2009=\u20090.009).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, we observed that a single dose of cefazolin as perioperative antibiotic prophylaxis may lead to higher rates of postoperative urinary tract infections, but it could potentially lower the incidence of acute rejection within six months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337578","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:29:44Z","timestamp":1763749784000},"page":"e0337578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical impact of prophylactic antibiotics in kidney transplantation: A retrospective observational cohort study with historical comparison"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3510-9175","authenticated-orcid":true,"given":"Sang Ah","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Myung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-5304","authenticated-orcid":true,"given":"Hyunwook","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"pone.0337578.ref001","doi-asserted-by":"crossref","first-page":"2054358118799692","DOI":"10.1177\/2054358118799692","article-title":"Incidence Rate of Post-Kidney Transplant Infection: A Retrospective Cohort Study Examining Infection Rates at a Large Canadian Multicenter Tertiary-Care Facility","volume":"5","author":"J Cowan","year":"2018","journal-title":"Can J Kidney Health Dis"},{"issue":"9","key":"pone.0337578.ref002","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13507","article-title":"Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"JD Goldman","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"pone.0337578.ref003","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12828","article-title":"The challenge of urinary tract infections in renal transplant recipients","volume":"20","author":"I Hollyer","year":"2018","journal-title":"Transplant Infectious Dis"},{"key":"pone.0337578.ref004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/ajt.12124","article-title":"Urinary tract infections in solid organ transplantation","author":"R Parasuraman","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"pone.0337578.ref005","article-title":"Surgical site infections: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"AST ID Community of Practice","year":"2019","journal-title":"Clin Transplant"},{"issue":"4","key":"pone.0337578.ref006","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.transproceed.2012.10.059","article-title":"Clinical significance of prophylactic antibiotics in renal transplantation","volume":"45","author":"SU Choi","year":"2013","journal-title":"Transplant Proc"},{"issue":"1","key":"pone.0337578.ref007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000001848","article-title":"Perioperative Antibiotic Prophylaxis to Prevent Surgical Site Infections in Solid Organ Transplantation","volume":"102","author":"JA Anesi","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"pone.0337578.ref008","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00345-018-2440-2","article-title":"Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers","volume":"37","author":"F Bachmann","year":"2019","journal-title":"World J Urol"},{"issue":"3","key":"pone.0337578.ref009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/TP.0000000000000381","article-title":"Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation","volume":"99","author":"MP Freire","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"pone.0337578.ref010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12882-019-1461-4","article-title":"Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation","volume":"20","author":"G Sanclemente","year":"2019","journal-title":"BMC Nephrol"},{"issue":"1","key":"pone.0337578.ref011","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"G Karam","year":"2016","journal-title":"Crit Care"},{"issue":"10","key":"pone.0337578.ref012","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1172\/JCI72333","article-title":"Antibiotics and the gut microbiota","volume":"124","author":"SR Modi","year":"2014","journal-title":"J Clin Invest"},{"issue":"6012","key":"pone.0337578.ref013","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1126\/science.1195568","article-title":"Has the microbiota played a critical role in the evolution of the adaptive immune system?","volume":"330","author":"YK Lee","year":"2010","journal-title":"Science"},{"issue":"1","key":"pone.0337578.ref014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12882-020-01750-8","article-title":"Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab","volume":"21","author":"YH Kim","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"pone.0337578.ref015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01864-19","article-title":"The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes","volume":"58","author":"MP Weinstein","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"2","key":"pone.0337578.ref016","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"M Haas","year":"2014","journal-title":"Am J Transplant"},{"issue":"4","key":"pone.0337578.ref017","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0b013e3182962cab","article-title":"Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation","volume":"96","author":"D Wojciechowski","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"pone.0337578.ref018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12879-022-07182-z","article-title":"Single-center experience with perioperative antibiotic prophylaxis and surgical site infections in kidney transplant recipients","volume":"22","author":"A Ostaszewska","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0337578.ref019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.surg.2014.06.007","article-title":"One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial","volume":"157","author":"G Orlando","year":"2015","journal-title":"Surgery"},{"issue":"2","key":"pone.0337578.ref020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.euf.2018.07.014","article-title":"European Association of Urology Guidelines on Renal Transplantation: Update 2018","volume":"4","author":"O Rodr\u00edguez Faba","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"1","key":"pone.0337578.ref021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"DW Bratzler","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"issue":"9","key":"pone.0337578.ref022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.it.2012.05.003","article-title":"Antibiotics, microbiota, and immune defense","volume":"33","author":"C Ubeda","year":"2012","journal-title":"Trends Immunol"},{"issue":"8","key":"pone.0337578.ref023","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/08820139.2020.1797778","article-title":"A Review of Immunomodulatory Effects of Fluoroquinolones","volume":"50","author":"S Assar","year":"2021","journal-title":"Immunol Invest"},{"issue":"7","key":"pone.0337578.ref024","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/TP.0000000000002169","article-title":"Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection","volume":"102","author":"K Rey","year":"2018","journal-title":"Transplantation"},{"issue":"7","key":"pone.0337578.ref025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/TP.0000000000000370","article-title":"Gut microbial community structure and complications after kidney transplantation: a pilot study","volume":"98","author":"JR Lee","year":"2014","journal-title":"Transplantation"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:29:48Z","timestamp":1763749788000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337578"}},"subtitle":[],"editor":[{"given":"Justyna","family":"Go\u0142\u0119biewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}